Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1984 1
1995 1
1996 1
2000 1
2001 1
2002 4
2011 1
2018 1
2021 1
2022 2
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

16 results

Results by year

Filters applied: . Clear all
Page 1
Biomarker-directed targeted therapy plus durvalumab in advanced non-small-cell lung cancer: a phase 2 umbrella trial.
Besse B, Pons-Tostivint E, Park K, Hartl S, Forde PM, Hochmair MJ, Awad MM, Thomas M, Goss G, Wheatley-Price P, Shepherd FA, Florescu M, Cheema P, Chu QSC, Kim SW, Morgensztern D, Johnson ML, Cousin S, Kim DW, Moskovitz MT, Vicente D, Aronson B, Hobson R, Ambrose HJ, Khosla S, Reddy A, Russell DL, Keddar MR, Conway JP, Barrett JC, Dean E, Kumar R, Dressman M, Jewsbury PJ, Iyer S, Barry ST, Cosaert J, Heymach JV. Besse B, et al. Nat Med. 2024 Mar;30(3):716-729. doi: 10.1038/s41591-024-02808-y. Epub 2024 Feb 13. Nat Med. 2024. PMID: 38351187 Free PMC article. Clinical Trial.
Immunotherapy for Head and Neck Squamous Cell Carcinoma.
Moskovitz J, Moy J, Ferris RL. Moskovitz J, et al. Curr Oncol Rep. 2018 Mar 3;20(2):22. doi: 10.1007/s11912-018-0654-5. Curr Oncol Rep. 2018. PMID: 29502288 Free PMC article. Review.
The anti PD1 agent, nivolumab, was recently approved by the FDA as a standard of care regimen for patients with platinum refractory recurrent/metastatic (R/M) HNSCC. Molecular pathways leading to resistance are starting to be identified, and work is underway to understand …
The anti PD1 agent, nivolumab, was recently approved by the FDA as a standard of care regimen for patients with platinum refractory recurren …
The association between geriatric assessment, muscle measures, and treatment-related toxicity in older adults with cancer: An Israeli prospective study.
Shachar SS, Bar-Sela G, Peer A, Moskovitz MT, Bareket-Samish A, Epstein J, Wollner M, Shafran I, Boukal A, Williams GR. Shachar SS, et al. J Geriatr Oncol. 2022 Nov;13(8):1203-1207. doi: 10.1016/j.jgo.2022.08.007. Epub 2022 Aug 19. J Geriatr Oncol. 2022. PMID: 35989184

Two sarcopenia definitions were used: i. for women SMI <41 cm(2)/m(2) regardless of body mass index (BMI), and for men SMI <43 cm(2)/m(2) for those with BMI of <25 and < 53 cm(2)/m(2) for those with BMI 25; and ii. SMI <38 cm(2)/m(2) for

…
Two sarcopenia definitions were used: i. for women SMI <41 cm(2)/m(2) regardless of body mass index (BMI), and for men SMI <43 …
Thymic B-cell activation in myasthenia gravis.
Levinson AI, Zweiman B, Lisak RP, Dziarski A, Moskovitz AR. Levinson AI, et al. Neurology. 1984 Apr;34(4):462-8. doi: 10.1212/wnl.34.4.462. Neurology. 1984. PMID: 6608064
The Impact of Comprehensive Genomic Profiling (CGP) on the Decision-Making Process in the Treatment of ALK-Rearranged Advanced Non-Small Cell Lung Cancer (aNSCLC) After Failure of 2nd/3rd-Generation ALK Tyrosine Kinase Inhibitors (TKIs).
Raphael A, Onn A, Holtzman L, Dudnik J, Urban D, Kian W, Cohen AY, Moskovitz M, Zer A, Bar J, Rabinovich NM, Grynberg S, Oedegaard C, Agbarya A, Peled N, Shochat T, Dudnik E. Raphael A, et al. Front Oncol. 2022 May 13;12:874712. doi: 10.3389/fonc.2022.874712. eCollection 2022. Front Oncol. 2022. PMID: 35646707 Free PMC article.
Time-to-treatment discontinuation (TTD) and overall survival (OS) with NLST were compared between the groups. RESULTS: In 20 eligible patients (median [m]age 63 years [range, 40-89], females 75%, adenocarcinoma 100%, failure of alectinib 90%, FoundationOne Liquid CDx 80%), …
Time-to-treatment discontinuation (TTD) and overall survival (OS) with NLST were compared between the groups. RESULTS: In 20 eligible patien …
Oxidative modifications of kynostatin-272, a potent human immunodeficiency virus type 1 protease inhibitor: potential mechanism for altered activity in monocytes/macrophages.
Davis DA, Read-Connole E, Pearson K, Fales HM, Newcomb FM, Moskovitz J, Yarchoan R. Davis DA, et al. Antimicrob Agents Chemother. 2002 Feb;46(2):402-8. doi: 10.1128/AAC.46.2.402-408.2002. Antimicrob Agents Chemother. 2002. PMID: 11796349 Free PMC article.
Previous studies have indicated that human immunodeficiency virus type 1 (HIV-1) protease inhibitors (PIs) are less active at blocking viral replication in HIV-1 infected peripheral blood monocytes/macrophages (M/M) than in HIV-1-infected T cells. We explored the hy …
Previous studies have indicated that human immunodeficiency virus type 1 (HIV-1) protease inhibitors (PIs) are less active at blocking viral …
Studying the Effects of Dissolved Noble Gases and High Hydrostatic Pressure on the Spherical DOPC Bilayer Using Molecular Dynamic Simulations.
Pavlyuk E, Yungerman I, Bliznyuk A, Moskovitz Y. Pavlyuk E, et al. Membranes (Basel). 2024 Apr 12;14(4):89. doi: 10.3390/membranes14040089. Membranes (Basel). 2024. PMID: 38668117 Free PMC article.
This allowed for the accurate modeling of the effects of hydrostatic pressure at an ambient pressure of 25 bar. The chosen pressure references the 240 m depth of seawater: the horizon frequently used by commercial divers, who comprise the primary patient population of the …
This allowed for the accurate modeling of the effects of hydrostatic pressure at an ambient pressure of 25 bar. The chosen pressure referenc …
Pembrolizumab as a monotherapy or in combination with platinum-based chemotherapy in advanced non-small cell lung cancer with PD-L1 tumor proportion score (TPS) ≥50%: real-world data.
Dudnik E, Moskovitz M, Rottenberg Y, Lobachov A, Mandelboim R, Shochat T, Urban D, Wollner M, Nechushtan H, Rotem O, Zer A, Daher S, Bar J; Israel Lung Cancer Group. Dudnik E, et al. Oncoimmunology. 2021 Jan 28;10(1):1865653. doi: 10.1080/2162402X.2020.1865653. Oncoimmunology. 2021. PMID: 33552685 Free PMC article.
Baseline characteristics were well balanced, except for age and ECOG PS differences in favor of group PCT. Median (m)TTD was 4.9 months (mo) (95% CI, 3.1-7.6) vs 8.0mo (95% CI, 4.7-15.6) (p-0.09), mOS was 12.5mo (95% CI, 9.8-16.4) vs 20.4mo (95% CI, 10.8-NR) (p-0.08), with …
Baseline characteristics were well balanced, except for age and ECOG PS differences in favor of group PCT. Median (m)TTD was 4.9 mont …
Identification and characterization of a putative active site for peptide methionine sulfoxide reductase (MsrA) and its substrate stereospecificity.
Moskovitz J, Poston JM, Berlett BS, Nosworthy NJ, Szczepanowski R, Stadtman ER. Moskovitz J, et al. J Biol Chem. 2000 May 12;275(19):14167-72. doi: 10.1074/jbc.275.19.14167. J Biol Chem. 2000. PMID: 10799493 Free article.
The recombinant yeast MsrA was used for general characterization of the enzyme. Its K(m) value was similar to the bovine MsrA and appreciably lower than the K(m) of the bacterial enzyme. ...
The recombinant yeast MsrA was used for general characterization of the enzyme. Its K(m) value was similar to the bovine MsrA and app …
Oral health status, salivary flow rate and salivary quality in children, adolescents and young adults with ADHD.
Hidas A, Noy AF, Birman N, Shapira J, Matot I, Steinberg D, Moskovitz M. Hidas A, et al. Arch Oral Biol. 2011 Oct;56(10):1137-41. doi: 10.1016/j.archoralbio.2011.03.018. Epub 2011 Apr 22. Arch Oral Biol. 2011. PMID: 21514566
AIM: The study investigated a possible relationship between the oral health status of children, adolescents and young adults diagnosed with ADHD, both with and without pharmacological intervention, and the following: salivary flow rate, oral mucosal pH, plaque index (PI), oral hy …
AIM: The study investigated a possible relationship between the oral health status of children, adolescents and young adults diagnosed with …
16 results